Some autism researchers and clinicians say they are boycotting the upcoming annual meeting of the International Society for Autism Research in Austin, Texas, because of the state’s controversial health policies and lack of COVID-19 mitigation strategies.

Lindsay Shea talks about her work, her “dirt kitchen,” fried sticky buns and why her lab doesn’t have a mascot.

Petrus de Vries is on a quest to outfit Africa, the continent of his birth, with trained autism researchers and service providers.

The current system to approve genetic and metabolic conditions for newborn screening can’t keep pace with research on new therapies. Don Bailey wants to bring it up to speed.

Andrew Whitehouse talks about his conservation efforts in the Australian Outback, what it’s like to be an identical twin and why he leaves work promptly at 5 p.m.

Cannabis-derived drugs are approved to treat only a small number of autism-related conditions, but many autistic people and their families experiment with medical marijuana to ease autism traits. In this special report, Spectrum rounds up what the science says about cannabis and autism.

When scientists successfully partner with autistic people, the autistic community gains a voice in autism research, and the data are more reliable, experts say. Here’s how to build a successful collaboration.

Fallout over two recent studies highlights the potential power of social media to shape science, and the shifting dynamics between researchers and the autistic community.

Hundreds of preschool-aged children in Kentucky began taking antipsychotic medicines in 2012, according to an analysis of Medicaid records. Lohr discusses what it will it take to get them behavioral therapies instead.

An autism brain imaging study published seven years ago received an expression of concern last month after its authors failed to uphold a promise to make their raw data freely available.